T
ech
CN
library_books
Mobile
library_books
Laptop/Pc
library_books
Smart Home
library_books
Audio
library_books
Games
Lastnews
Topics
Trending
News
Best Pick
Reviews
How To Do
Search ...
Sandoz launches biosimilar Pyzchiva® (ustekinumab-ttwe) in the US, offering new treatment for around 12 million patients[1-4]
Notified -...
Teva and Alvotech Announce SELARSDI™ (ustekinumab-aekn) Injection Now Available in the U.S.
Notified -...
Alvotech and Teva Announce U.S. FDA Approval of Additional Presentation of SELARSDI™ (ustekinumab-aekn), Expanding its Label to Include Further Indications Approved for Reference Product, Stelara® (ustekinumab)
...
Sandoz launches biosimilar Pyzchiva® (ustekinumab) across Europe, to treat chronic inflammatory diseases
...
FDA approves biosimilar Pyzchiva® (ustekinumab-ttwe), to be commercialized by Sandoz in US
...
Sandoz confirms European Commission approval of Pyzchiva® (ustekinumab), further strengthening immunology offering
...
menu
TechCN
person
menu
![Sandoz launches biosimilar Pyzchiva® (ustekinumab-ttwe) in the US, offering new treatment for around 12 million patients[1-4]](http://globenewswire.vietreader.com/thumb/190x300/2018-01/1515317794_image.png)
